Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea

BACKGROUND: Obstructive sleep apnea (OSA) has been suggested as an independent risk factor for nonalcoholic fatty liver disease (NAFLD), and continuous positive airway pressure (CPAP) is the first-line therapy for OSA. AIM: To clarify the efficacy of effective CPAP therapy on NAFLD of OSA patients b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirono, Haruka, Watanabe, Kazuhiko, Hasegawa, Katsuhiko, Kohno, Masaki, Terai, Shuji, Ohkoshi, Shogo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Prospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283589/
https://www.ncbi.nlm.nih.gov/pubmed/34307562
http://dx.doi.org/10.12998/wjcc.v9.i19.5112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283589/
https://www.ncbi.nlm.nih.gov/pubmed/34307562
http://dx.doi.org/10.12998/wjcc.v9.i19.5112

Ejemplares similares